First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday
U.S. stocks mixed; First Tracks Biotherapeutics surged 18% on positive celiac trial results, while C3.ai, Liquidia and others also gained.
Stocks · News reference
Allot Raises FY2026 Sales Guidance from $113.000M-$117.000M to $115.000M-$118.000M vs $115.795M Est
Allot (NASDAQ:ALLT) raises FY2026 sales outlook from $113.000 million-$117.000 million to $115.000 million-$118.000 million vs $115.795 million estimate.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
U.S. Cybersecurity Agencies Warn China-Based Cybersecurity Company Enabling Threat Actors To Target Multiple Critical Infrastructure Sectors Worldwide
Shares of cybersecurity-related companies are trading higher. The sector may be experiencing rotational interest from investors as a hedge against continued AI tool deployment, which may yield more demand for more security, or as a haven against weakness in AI-related tech stocks.
Unconfirmed Social Media Reports Suggest The ShinyHunters Hacking Group Claims To Have Breached The FBI, Stating The Attack Is "Not Financially Motivated." The FBI Has Not Yet Commented.